in this issue
Chemical Week Magazine :: Business & Finance :: Europe/Mideast
Bayer Sees Slow Growth; Targets Higher Pharma Rank
9:15 AM MST | March 2, 2012 | —Natasha Alperowicz in Leverkusen
Bayer says its fourth-quarter and full-year 2011 results, announced on February 28, were a success despite a challenging economic environment. The company also provided guidance for 2012, saying that it expects sales to increase by about 3% with “slight improvements in Ebitda before special items and core earnings per share.” Dekkers: Good pharma pipeline. Thomas: Chinese growth slowed. Bayer’s fourth-quarter net income reached €397 million ($534.1 million), compared with a loss of €145 million in the year-earlier period. Sales were...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee